Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 7/20 | 0.44 |
| ▸ | FLT1 | P17948 | 1/20 | 0.44 |
| ▸ | BRAF | P15056 | 5/20 | 0.42 |
| ▸ | FPR2 | P25090 | 1/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 8/20 | 0.42 |
| ▸ | MAPK13 | O15264 | 3/20 | 0.41 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.40 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | KIT | P10721 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.40 |
| ▸ | AXL | P30530 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29834614 | 1.00 | CYP17A1 (0.46) | CYP17A1KDRFLT1BRAFFPR2 | |
| SCHEMBL24037398 | 0.84 | MAPK14 (0.48) | CYP17A1KDRFLT1BRAFMAPK14 | |
| SCHEMBL29834713 | 0.83 | BRAF (0.47) | CYP17A1KDRFLT1BRAFMAPK14 | |
| SCHEMBL23368030 | 0.82 | NPC1 (0.46) | CYP17A1AAK1 | |
| SCHEMBL30203084 | 0.82 | NPC1 (0.46) | CYP17A1AAK1 | |
| SCHEMBL29834669 | 0.81 | CYP17A1 (0.48) | CYP17A1KDRFLT1BRAFMAPK14 | |
| SCHEMBL30729902 | 0.81 | MAPK14 (0.53) | CYP17A1KDRFLT1BRAFMAPK14 | |
| SCHEMBL16895218 | 0.81 | MAPK14 (0.53) | CYP17A1KDRFLT1BRAFMAPK14 | |
| SCHEMBL24037629 | 0.80 | BRAF (0.47) | CYP17A1KDRFLT1BRAFMAPK14 | |
| SCHEMBL2858354 | 0.80 | MAPK14 (0.63) | CYP17A1KDRFLT1BRAFMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021231400-A1 | BIS-ARYL ETHERS CONTAINING N-ACYL AZETIDINE AS EGFR/HER2 INHIBITORS | ACCUTAR BIOTECHNOLOGY, INC. (US) | 2021-11-18 | — | — | WO | disclosed |